Genome Editing, Gene Drives, and Synthetic Biology: Will They Contribute to Disease-Resistant Crops, and Who Will Benefit?

IF 9.1 1区 农林科学 Q1 PLANT SCIENCES
Annual review of phytopathology Pub Date : 2019-08-25 Epub Date: 2019-05-31 DOI:10.1146/annurev-phyto-080417-045954
Kevin V Pixley, Jose B Falck-Zepeda, Ken E Giller, Leland L Glenna, Fred Gould, Carol A Mallory-Smith, David M Stelly, C Neal Stewart
{"title":"Genome Editing, Gene Drives, and Synthetic Biology: Will They Contribute to Disease-Resistant Crops, and Who Will Benefit?","authors":"Kevin V Pixley,&nbsp;Jose B Falck-Zepeda,&nbsp;Ken E Giller,&nbsp;Leland L Glenna,&nbsp;Fred Gould,&nbsp;Carol A Mallory-Smith,&nbsp;David M Stelly,&nbsp;C Neal Stewart","doi":"10.1146/annurev-phyto-080417-045954","DOIUrl":null,"url":null,"abstract":"<p><p>Genetically engineered crops have been grown for more than 20 years, resulting in widespread albeit variable benefits for farmers and consumers. We review current, likely, and potential genetic engineering (GE) applications for the development of disease-resistant crop cultivars. Gene editing, gene drives, and synthetic biology offer novel opportunities to control viral, bacterial, and fungal pathogens, parasitic weeds, and insect vectors of plant pathogens. We conclude that there will be no shortage of GE applications totackle disease resistance and other farmer and consumer priorities for agricultural crops. Beyond reviewing scientific prospects for genetically engineered crops, we address the social institutional forces that are commonly overlooked by biological scientists. Intellectual property regimes, technology regulatory frameworks, the balance of funding between public- and private-sector research, and advocacy by concerned civil society groups interact to define who uses which GE technologies, on which crops, and for the benefit of whom. Ensuring equitable access to the benefits of genetically engineered crops requires affirmative policies, targeted investments, and excellent science.</p>","PeriodicalId":8251,"journal":{"name":"Annual review of phytopathology","volume":"57 ","pages":"165-188"},"PeriodicalIF":9.1000,"publicationDate":"2019-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1146/annurev-phyto-080417-045954","citationCount":"52","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annual review of phytopathology","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1146/annurev-phyto-080417-045954","RegionNum":1,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/5/31 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PLANT SCIENCES","Score":null,"Total":0}
引用次数: 52

Abstract

Genetically engineered crops have been grown for more than 20 years, resulting in widespread albeit variable benefits for farmers and consumers. We review current, likely, and potential genetic engineering (GE) applications for the development of disease-resistant crop cultivars. Gene editing, gene drives, and synthetic biology offer novel opportunities to control viral, bacterial, and fungal pathogens, parasitic weeds, and insect vectors of plant pathogens. We conclude that there will be no shortage of GE applications totackle disease resistance and other farmer and consumer priorities for agricultural crops. Beyond reviewing scientific prospects for genetically engineered crops, we address the social institutional forces that are commonly overlooked by biological scientists. Intellectual property regimes, technology regulatory frameworks, the balance of funding between public- and private-sector research, and advocacy by concerned civil society groups interact to define who uses which GE technologies, on which crops, and for the benefit of whom. Ensuring equitable access to the benefits of genetically engineered crops requires affirmative policies, targeted investments, and excellent science.

基因组编辑、基因驱动和合成生物学:它们会对抗病作物做出贡献吗?谁将受益?
基因工程作物已经种植了20多年,给农民和消费者带来了广泛的好处,尽管好处不尽相同。我们综述了目前、可能和潜在的基因工程(GE)在开发抗病作物品种方面的应用。基因编辑、基因驱动和合成生物学为控制病毒、细菌和真菌病原体、寄生杂草和植物病原体的昆虫载体提供了新的机会。我们的结论是,将不缺乏转基因应用来解决农作物的抗病性和其他农民和消费者优先考虑的问题。除了回顾转基因作物的科学前景之外,我们还讨论了生物科学家通常忽视的社会制度力量。知识产权制度、技术监管框架、公共和私营部门研究之间的资金平衡以及相关的民间社会团体的倡导相互作用,决定了谁使用哪种转基因技术、使用哪种作物,以及为谁的利益服务。确保公平获得转基因作物的好处需要积极的政策、有针对性的投资和优秀的科学。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annual review of phytopathology
Annual review of phytopathology 生物-植物科学
CiteScore
16.60
自引率
1.00%
发文量
19
期刊介绍: The Annual Review of Phytopathology, established in 1963, covers major advancements in plant pathology, including plant disease diagnosis, pathogens, host-pathogen Interactions, epidemiology and ecology, breeding for resistance and plant disease management, and includes a special section on the development of concepts. The journal is now open access through Annual Reviews' Subscribe to Open program, with articles published under a CC BY license.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信